DRASC
Dead / Abandoned — Abandoned — failure to respond (as of 16 Feb 2021)
What this means for you
This application is over — abandoned 04 Feb 2021. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 88096818
- Mark type
- Stylized text
- Filed
- 29 Aug 2018
- Published for opposition
- 19 Feb 2019
- Abandoned
- 04 Feb 2021
- Attorney of record
- Devon E. White
Goods and services
- Class 042 — Scientific and technological services: Medical and scientific research, namely, conducting clinical trials for others; Pharmaceutical drug development services; Research and development in the pharmaceutical and biotechnology fields; Medical and scientific research in the field of cancer treatment and diagnosis; Research and development of pharmaceuticals for the treatment of age-related diseases and cancer; Software as a service (SAAS) services featuring software for precision oncology drug library screening; Product research and development, namely, testing of the newest drugs through high-throughput smart-screening platform to determine the best pharmacological treatments for an individual patient; Pharmacological product research consultation services that will enable others, namely, doctors and clinicians, to select and recommend the appropriate treatment for patients through the use of data obtained through personalized pharmacogenetics, genomics, proteomics and other biological testing
- Class 044 — Medical, beauty and agricultural services: Medical testing for diagnostic or treatment purposes; Providing cancer screening services; Genetic counseling; Genetic testing for medical purposes; Health care services for treating cancer; Medical analysis services for the diagnosis of cancer; Providing personalized healthcare and medical information in the nature of providing medical information and reports that will enable doctors and clinicians to select and recommend the appropriate treatment for patients through the use of data obtained through personalized pharmacogenetics, genomics, proteomics and other biological testing, individual behaviors including medication compliance, exercise, diet, sleep patterns and language, epigenetic and environmental factors, and bioinformatics analysis
Owner
- AccuBeing, LLC, Chapel Hill, NC, US
- AccuBeing, LLC, Chapel Hill, NC, US
Prosecution history
- 16 Feb 2021 — ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
- 16 Feb 2021 — ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
- 03 Aug 2020 — NOTIFICATION OF FINAL REFUSAL EMAILED
- 03 Aug 2020 — FINAL REFUSAL E-MAILED
- 03 Aug 2020 — SU - FINAL REFUSAL - WRITTEN
- 29 Jul 2020 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 28 Jul 2020 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 28 Jul 2020 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 28 Apr 2020 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 28 Apr 2020 — NON-FINAL ACTION E-MAILED
- 28 Apr 2020 — SU - NON-FINAL ACTION - WRITTEN
- 09 Apr 2020 — STATEMENT OF USE PROCESSING COMPLETE
- 24 Mar 2020 — USE AMENDMENT FILED
- 09 Apr 2020 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 24 Mar 2020 — TEAS STATEMENT OF USE RECEIVED